NASDAQ:ELAB - Nasdaq - US73017P2011 - Common Stock - Currency: USD
2.26
+0.04 (+1.8%)
The current stock price of ELAB is 2.26 USD. In the past month the price decreased by -53.69%. In the past year, price decreased by -99.76%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UL | UNILEVER PLC-SPONSORED ADR | 23.63 | 153.83B | ||
KVUE | KENVUE INC | 20.18 | 44.15B | ||
EL | ESTEE LAUDER COMPANIES-CL A | 25.06 | 21.36B | ||
BRBR | BELLRING BRANDS INC | 36.14 | 9.64B | ||
COTY | COTY INC-CL A | 17.75 | 4.33B | ||
IPAR | INTERPARFUMS INC | 20.78 | 3.48B | ||
ELF | ELF BEAUTY INC | 19.47 | 3.45B | ||
ODD | ODDITY TECH LTD-CL A | 22.69 | 2.47B | ||
EPC | EDGEWELL PERSONAL CARE CO | 10.66 | 1.50B | ||
OLPX | OLAPLEX HOLDINGS INC | 11.82 | 864.01M | ||
HLF | HERBALIFE LTD | 3.4 | 675.94M | ||
HNST | HONEST CO INC/THE | N/A | 529.10M |
PMGC Holdings, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. The company is headquartered in Newport Beach, California and currently employs 2 full-time employees. The company went IPO on 2023-11-21. The Company’s portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is a research and development subsidiary of the Company, which is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment vehicle engaging in investing, lending, and seeking diversified investment opportunities across various markets.
PMGC HOLDINGS INC
120 Newport Center Drive, Ste 250
Newport Beach CALIFORNIA US
Employees: 18
Company Website: https://pmgcholdings.com/
Investor Relations: http://elevailabs.com/
Phone: 18667944940
The current stock price of ELAB is 2.26 USD. The price increased by 1.8% in the last trading session.
The exchange symbol of PMGC HOLDINGS INC is ELAB and it is listed on the Nasdaq exchange.
ELAB stock is listed on the Nasdaq exchange.
PMGC HOLDINGS INC (ELAB) has a market capitalization of 1.60M USD. This makes ELAB a Nano Cap stock.
PMGC HOLDINGS INC (ELAB) currently has 18 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ELAB does not pay a dividend.
PMGC HOLDINGS INC (ELAB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-315.86).
ChartMill assigns a fundamental rating of 3 / 10 to ELAB. ELAB has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months ELAB reported a non-GAAP Earnings per Share(EPS) of -315.86. The EPS decreased by -347350% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -48.81% | ||
ROE | -63.93% | ||
Debt/Equity | 0 |